Related Experiment Video
Updated: Dec 18, 2025

08:00
Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
6.4K
Blocking Extracellular Chaperones to Improve Cardiac Regeneration
Laura Seclì1, Matteo Sorge1, Alessandro Morotti2
1Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Frontiers in Bioengineering and Biotechnology
|June 13, 2020
Summary
Blocking extracellular chaperone proteins can improve heart function after damage. This approach, combined with tissue engineering, offers a promising future for cardiac regenerative medicine.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Regenerative Medicine
Background:
- Myocardial insults cause cardiomyopathy and heart failure due to limited cardiomyocyte regeneration.
- Chaperone proteins are vital for cardiomyocyte health, regulating protein folding and turnover.
- Extracellular chaperone proteins released during cell damage can promote inflammation and apoptosis, harming heart function.
Purpose of the Study:
- To investigate the detrimental role of extracellular chaperone proteins in myocardial damage.
- To evaluate the therapeutic potential of blocking extracellular chaperone activity in cardiac conditions.
- To explore the combination of chaperone inhibition and tissue engineering for cardiac repair.
Main Methods:
- Preclinical models of myocardial infarction and cardiomyopathy were utilized.
- The effects of blocking extracellular chaperone activity on heart function were assessed.
- Investigated the potential synergy between chaperone inhibition and tissue engineering strategies.
Main Results:
- Blocking extracellular chaperone activity demonstrated beneficial effects on heart function in preclinical models.
- Evidence suggests extracellular chaperones contribute to inflammation and cardiomyocyte apoptosis post-insult.
- The study highlights the dual role of chaperone proteins in cardiac health and disease.
Conclusions:
- Inhibition of extracellular chaperone proteins represents a potential therapeutic strategy for heart failure.
- Combining chaperone blockade with tissue engineering may advance cardiac regenerative medicine.
- Understanding extracellular chaperone function is crucial for developing novel cardiac therapies.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
796
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
796
Heart Failure Drugs: Inotropic Agents
1.1K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.1K

